Resistance mechanisms of immune checkpoint inhibition in lymphoma: Focusing on the tumor microenvironment

Immune checkpoint inhibitors (ICIs) have revolutionized the therapeutic strategies of multiple types of malignancies including lymphoma. However, efficiency of ICIs varies dramatically among different lymphoma subtypes, and durable response can only be achieved in a minority of patients, thus requir...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Chunlan, Wang, Leiming, Xu, Caigang, Xu, Heng, Wu, Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10027765/
https://www.ncbi.nlm.nih.gov/pubmed/36959853
http://dx.doi.org/10.3389/fphar.2023.1079924

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10027765/
https://www.ncbi.nlm.nih.gov/pubmed/36959853
http://dx.doi.org/10.3389/fphar.2023.1079924

Ejemplares similares